115 related articles for article (PubMed ID: 3011535)
21. Interaction of a water-soluble derivative of delta-9-tetrahydrocannabinol with [3H]diazepam and [3H]flunitrazepam binding to rat brain membranes.
Sung SC; Jakubovic A
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):335-40. PubMed ID: 2819954
[TBL] [Abstract][Full Text] [Related]
22. Modulation of (+)-[3H]pentazocine binding to guinea pig cerebellum by divalent cations.
Basile AS; Paul IA; Mirchevich A; Kuijpers G; De Costa B
Mol Pharmacol; 1992 Nov; 42(5):882-9. PubMed ID: 1279378
[TBL] [Abstract][Full Text] [Related]
23. Divalent cation competition with [3H]saxitoxin binding to tetrodotoxin-resistant and -sensitive sodium channels. A two-site structural model of ion/toxin interaction.
Doyle DD; Guo Y; Lustig SL; Satin J; Rogart RB; Fozzard HA
J Gen Physiol; 1993 Feb; 101(2):153-82. PubMed ID: 8384241
[TBL] [Abstract][Full Text] [Related]
24. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
De Vries DJ; Beart PM
Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
[TBL] [Abstract][Full Text] [Related]
25. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding.
Glossmann H; Ferry DR; Lübbecke F; Mewes R; Hofmann F
J Recept Res; 1983; 3(1-2):177-90. PubMed ID: 6304295
[TBL] [Abstract][Full Text] [Related]
26. Effects of protein restriction, melatonin administration, and short daylength on brain benzodiazepine receptors in prepubertal male rats.
Kennaway DJ; Royles P; Webb H; Carbone F
J Pineal Res; 1988; 5(5):455-67. PubMed ID: 2845046
[TBL] [Abstract][Full Text] [Related]
27. Labelling of diazepam-sensitive and -insensitive benzodiazepine receptors with [3H]tert-butyl-8-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo [1,5-a][1,4]benzodiazepine 3-carboxylate (ZG-63).
Wong G; Gu ZQ; de Costa B; Skolnick P
Eur J Pharmacol; 1993 Sep; 247(1):57-63. PubMed ID: 8258361
[TBL] [Abstract][Full Text] [Related]
28. The benzodiazepine/alcohol antagonist Ro 15-4513: binding to a GABAA receptor subtype that is insensitive to diazepam.
Turner DM; Sapp DW; Olsen RW
J Pharmacol Exp Ther; 1991 Jun; 257(3):1236-42. PubMed ID: 1646328
[TBL] [Abstract][Full Text] [Related]
29. Modulation of GABA receptor binding by Ca2+.
Corda MG; Guidotti A
J Neurochem; 1983 Jul; 41(1):277-80. PubMed ID: 6306170
[TBL] [Abstract][Full Text] [Related]
30. Non-benzodiazepine, Ag-dependent, brain-specific binding sites for [3H]beta-carboline-3-carboxylic acid ethyl ester.
Korneyev AYa ; Meliksetyan MB
Eur J Pharmacol; 1989 Dec; 173(2-3):201-5. PubMed ID: 2560435
[TBL] [Abstract][Full Text] [Related]
31. Bidirectional modulation of GABA-gated chloride channels by divalent cations: inhibition by Ca2+ and enhancement by Mg2+.
Schwartz RD; Wagner JP; Yu X; Martin D
J Neurochem; 1994 Mar; 62(3):916-22. PubMed ID: 8113813
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of GABAA ligand-gated Cl- channels by zinc in adult rat brain: a regional study.
Ito Y; Segawa K; Kobayashi M; Fukuda H
Neurochem Res; 1996 Aug; 21(8):955-61. PubMed ID: 8895850
[TBL] [Abstract][Full Text] [Related]
33. Extracellular divalent and trivalent cation effects on sodium current kinetics in single canine cardiac Purkinje cells.
Hanck DA; Sheets MF
J Physiol; 1992 Aug; 454():267-98. PubMed ID: 1335501
[TBL] [Abstract][Full Text] [Related]
34. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological properties of the GABA(A) receptor complex from brain regions of (hypoemotional) Roman high- and (hyperemotional) low-avoidance rats.
Bentareha R; Araujo F; Ruano D; Driscoll P; Escorihuela RM; Tobeña A; Fernández-Teruel A; Vitorica J
Eur J Pharmacol; 1998 Jul; 354(1):91-7. PubMed ID: 9726635
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of ion permeation pathway in the N-type Ca2+ channel.
Wakamori M; Strobeck M; Niidome T; Teramoto T; Imoto K; Mori Y
J Neurophysiol; 1998 Feb; 79(2):622-34. PubMed ID: 9463426
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of brain [3H]diazepam binding sites in chronic caffeine treated rats.
Wu PH; Phillis JW
Gen Pharmacol; 1986; 17(4):501-3. PubMed ID: 3019827
[TBL] [Abstract][Full Text] [Related]
38. Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sites.
Mantione CR; Goldman ME; Martin B; Bolger GT; Lueddens HW; Paul SM; Skolnick P
Biochem Pharmacol; 1988 Jan; 37(2):339-47. PubMed ID: 2829915
[TBL] [Abstract][Full Text] [Related]
39. Two calcium-binding sites mediate the interconversion of liver inositol 1,4,5-trisphosphate receptors between three conformational states.
Marshall IC; Taylor CW
Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):591-8. PubMed ID: 8043006
[TBL] [Abstract][Full Text] [Related]
40. Inhibition by cations of antagonist binding to histamine H1-receptors: differential effect of sodium ions on the binding of two radioligands.
Treherne JM; Stern JS; Flack WJ; Young JM
Br J Pharmacol; 1991 Jul; 103(3):1745-51. PubMed ID: 1681976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]